AMETEK, Inc. announced that it has completed two acquisitions: Brookfield Engineering Laboratories, the world’s leading manufacturer of viscometers and rheometers, and ESP/SurgeX, a leader in energy intelligence and power protection solutions.
“Brookfield Engineering and ESP/SurgeX are excellent acquisitions and strong additions to our Electronic Instruments Group. These businesses will allow us to expand our presence in laboratory instrumentation and power protection, two attractive growth platforms,” comments Frank S. Hermance, AMETEK Chairman and Chief Executive Officer.
Brookfield Engineering
Brookfield offers a complete range of viscometers and rheometers as well as instrumentation to analyze texture and powder flow. Its products are used primarily for quality control applications in the manufacture of products in a broad range of markets including food and beverage, pharmaceuticals, oil and gas, paints, solvents, chemicals, coatings and packaging.
“Brookfield is an outstanding acquisition. It is the global leader in viscosity measurement instrumentation. Its products and technologies complement our existing laboratory instrumentation businesses and provide us with opportunities to expand that business platform into a broader range of markets and applications,” comments Mr. Hermance.
Brookfield Engineering Laboratories, with annual sales of approximately $55 million, was acquired for approximately $167 million. Headquartered in Middleboro, MA, with additional operations in Germany, the United Kingdom, China and India, Brookfield joins AMETEK as a unit of its Instrumentation and Specialty Controls division within the AMETEK Electronic Instruments Group (EIG).
Corporate Profile
AMETEK is a leading global manufacturer of electronic instruments and electro-mechanical devices with annual sales of $4.0 billion. AMETEK’s Corporate Growth Plan is based on Four Key Strategies: Operational Excellence, Strategic Acquisitions, Global & Market Expansion and New Products. AMETEK’s objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500 Index.
